Avity Investment Management Inc. Sells 112,745 Shares of GE HealthCare Technologies Inc. $GEHC

Avity Investment Management Inc. lowered its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 91.6% in the 3rd quarter, Holdings Channel.com reports. The fund owned 10,300 shares of the company’s stock after selling 112,745 shares during the period. Avity Investment Management Inc.’s holdings in GE HealthCare Technologies were worth $774,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Wedge Capital Management L L P NC purchased a new stake in shares of GE HealthCare Technologies in the third quarter worth $26,859,000. Valicenti Advisory Services Inc. grew its position in GE HealthCare Technologies by 22.6% during the third quarter. Valicenti Advisory Services Inc. now owns 68,107 shares of the company’s stock worth $5,115,000 after buying an additional 12,550 shares in the last quarter. Locust Wood Capital Advisers LLC increased its stake in GE HealthCare Technologies by 7.1% in the 3rd quarter. Locust Wood Capital Advisers LLC now owns 2,084,337 shares of the company’s stock worth $156,534,000 after acquiring an additional 137,992 shares during the last quarter. Nan Fung Trinity HK Ltd. bought a new position in GE HealthCare Technologies in the 3rd quarter worth about $23,206,000. Finally, Temasek Holdings Private Ltd purchased a new stake in shares of GE HealthCare Technologies in the 3rd quarter valued at about $99,922,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ:GEHC opened at $72.34 on Wednesday. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. The company has a 50-day moving average price of $80.24 and a 200-day moving average price of $78.52. The company has a market cap of $32.97 billion, a price-to-earnings ratio of 15.86, a price-to-earnings-growth ratio of 1.59 and a beta of 1.03. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The company had revenue of $5.70 billion for the quarter, compared to analysts’ expectations of $5.60 billion. During the same period last year, the firm earned $1.45 earnings per share. GE HealthCare Technologies’s quarterly revenue was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.07%.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. UBS Group lowered GE HealthCare Technologies from a “neutral” rating to a “sell” rating and boosted their price objective for the stock from $73.00 to $77.00 in a report on Thursday, January 15th. Morgan Stanley increased their price objective on GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 4th. Wall Street Zen upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, March 7th. Wells Fargo & Company upped their target price on GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Finally, The Goldman Sachs Group reissued a “buy” rating and set a $98.00 price target on shares of GE HealthCare Technologies in a research note on Friday, January 9th. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $92.17.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.